Old Web
English
Sign In
Acemap
>
authorDetail
>
D Lindner
D Lindner
Takeda Pharmaceutical Company
Physical therapy
Diabetes mellitus
Medicine
Internal medicine
Vedolizumab
5
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DOP15 Transmural healing with vedolizumab in patients with active Crohn’s disease
2020
Journal of Crohns & Colitis
Jordi Rimola
J.-F. Colombel
Brian Bressler
Shashi Adsul
Jenifer Siegelman
P E Cole
D Lindner
Silvio Danese
Show All
Source
Cite
Save
Citations (0)
DOP60 Vedolizumab treatment persistence and safety in an extended access program (XAP)
2020
Journal of Crohns & Colitis
Silvio Danese
K Subramanian
J. Van Zyl
Shashi Adsul
D Lindner
Jeannine Roth
S Vermeire
Show All
Source
Cite
Save
Citations (0)
P376 Effects of IV vedolizumab on health-related quality of life and work productivity in patients with Crohn’s disease: results from the Phase 3b VERSIFY trial
2019
Journal of Crohns & Colitis
S. Danese
S Adsul
D Lindner
S Jones
Haridarshan Patel
J.-F. Colombel
Show All
Source
Cite
Save
Citations (1)
P537 The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials
2019
Journal of Crohns & Colitis
Parambir S. Dulai
Laurent Peyrin-Biroulet
K. Hahn
N Khalife
D Lindner
Karen Lasch
D Demuth
Haridarshan Patel
Jairath
Show All
Source
Cite
Save
Citations (1)
P436 Darvadstrocel treatment outcomes in Crohn’s disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD
2019
Journal of Crohns & Colitis
J. Panes
Damián García Olmo
D Lindner
I Tagarro García
C Agboton
Show All
Source
Cite
Save
Citations (0)
1